Below is the message/email people are talking about. Funny
Below is the message/email people are talking about. Funny some are 'so upset'
Was totally predictable, which is why I stocked up on Tollovid. My logic was...
If the Phase II data was good, Tollovid would sell out
If Todos got a EUA, that would impact Tollovid as well
"We will see what happens with Daily in the months ahead. May be temporary - but right now as we engage with regulators we have been told this is the prudent way to go."
I read this as, regulators want assurances if they grant a EUA, Todos has enough Tollovir to supply all the hospitals.
Remember Gerald has said in the past they had plenty and the supply chain wasn't going to be an issue. Well 'plenty' is now reserved.
The only way I can read this is a very good thing for shareholders and for which ever countries that are looking into granting an EUA if that happens. With no side effects, it seems like a no brainer to me. What do you have to lose?
Gerald Commissiong @G_Commish 10h
Given increasing demand from LC users having success & need to ensure continued acute user success in face of emerging nasty descendant taking over WW, Tollovid Max is focus due to IC50 binding strength. Will see how Daily performs from clients over next weeks. Wanted to give enough time for users to stock up with supply for them/their families. We are beefing up Tollovir planning substantially. Daily is a great product. Right now as we interact with regulators for Tollovir we need to be careful - this discontinuation could end up being temporary.
Tollovid™ Daily
Is Going Away
Dear Tollovid Immunity Community,
As we grow our brand we are getting more believers in Tollovid™! The video below shows some popular names from the Celebrity Sweat® flag football game during Superbowl weekend and their endorsement of Tollovid™.
However, due to supply chain issues, we are forced to discontinue the production of Tollovid™ Daily. While supplies last, we are offering a 10% discount to our valued customers with code 10%off.
In conjunction, we currently have a limited-time promotion on Tollolvid™ Max buy 2 bottles and get 1 Tollovid™ Max FREE or take advantage of code $50off to get $50 off a bottle of Tollovid™ Max.
Thank you for your continued support of Tollovid™.
3
Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...
Continue Reading
TVEyes Archive+ Takes Media Intelligence to New Heights Dishing out another update here, folks. TVEyes, the media intelligence powerhouse, just kicked off something that's got the potential to change the strategic media game—they call it Archive+. This tool isn’t just plundering old tapes; we're talking nearly two damn decades worth of historical broadcasts and...
Continue Reading
Unlocking Lifelong Success: The Early Advantage Ever look at a successful adult and wonder, "Where'd they get that spark?" According to HelloNation and child care expert Karen Ego, it all starts early. Think of early learning not just as prepping for school, but as the first blueprint for life's journey. It's the skills you pick up in those tender years that stick it out...
Continue Reading
Testing the Waters with Education Stake Talk about mixing oil and water. Scienjoy Holding Corporation, those tech-savvy folks from China's live streaming circles, have set their sights on education with a hefty 29.9% stake in Leader Education Limited. For HK$102.69 million, that’s about US$13.1 million, they’re jumping into an industry with a different flavor....
Continue Reading
MD Integrations Paves a New Path in Telehealth Well, folks, it seems someone’s finally listening. MD Integrations is taking a serious swing at solving one of telehealth's big hiccups – compliance delays. By roping in LegitScript directly, they’re all set to smooth the rocky road to launching virtual care brands. The Sticky Issue of Compliance Delays Anyone dabbling...
Continue Reading
Untangling the Mess Behind Game Day Ever wonder why getting to your seat at a sports event feels seamless? It's like magic with your ticket appearing as a barcode on your phone, the concession stand knowing your order from last week's game, and sponsor ads personalized just for you. This is no easy feat. Behind the scenes, though, it's akin to a game of Twister. The...
Continue Reading
The Future of Education Shaped Today There's a profound shift happening in higher education, and it's not the usual undergrad grind most folks think of. Cate Tolnai, stepping into her role at the University of Phoenix, is in the thick of it. She's set to join the UPCEA Council for Credential Innovation's leadership team, and that isn't some fluff title. Her appointment...
Continue Reading
Triskell Software Makes Its Mark Kicking off September 2026 with a bang, Triskell Software finds itself on the illustrious 2026 Gartner Magic Quadrant for Adaptive Project Management and Reporting (APMR). This marks the first time the Madrid-based company nabs a spot here, and it's a significant feather in their cap. Just think, out of the 11 vendors invited to this...
Continue Reading
Insurance Innovation Hits Missouri Here's something you don't see every day: an insurance company pushing tech boundaries, and it goes by the name Lemonade. This company, trading under NYSE:LMND, is throwing something fresh at Missouri—car insurance that's not just another spoonful of the same old. They've paired Lemonade Car with Lemonade Autonomous Car, offering a...
Continue Reading
Nashville Welcomes A New Wave of Pet Care In a world where convenience is king, BlueSky At-Home Veterinary Care is stepping up to the plate—or should I say, doorstep—by rolling out its fresh take on veterinary services in Nashville. Kicking off on September 15, 2026, this isn't just any ol' run-of-the-mill clinic opening. We're talking about vets coming straight to...
Continue Reading
Top 5 Most Recently Viewed Articles
Thryv Announces New Sales Leadership Team Thryv (NASDAQ: THRY), recognized as a leading software platform catering to small businesses, has taken a significant step forward with two pivotal appointments within its sales leadership. The company has promoted Fran Lee to serve as the Vice President of North American Sales. In his elevated position, Lee will navigate the...
Continue Reading
Danske Bank's Share Buy-Back Initiative: A Closer Look Danske Bank A/S has recently undertaken a significant move by launching a share buy-back program totaling DKK 5.5 billion, which aims to repurchase up to 70 million shares. This program, announced in early February, is set to unfold over the course of nearly a year, demonstrating the bank's commitment to returning...
Continue Reading
Investor Alert: Ongoing Investigation of DexCom As investment opportunities continue to evolve, it's vital to protect your rights as an investor. If you've lost more than $100,000 in DexCom, you’re encouraged to connect with Faruqi & Faruqi, LLP, a reputable national securities law firm known for its dedication to advocating for shareholders. Legal Options for Investors...
Continue Reading
Impressive Growth of Vanguard Information Tech ETF Vanguard Information Tech ETF (NYSE: VGT) has shown remarkable performance over the past decade, consistently outpacing the overall market by a substantial margin of 8.6% on an annualized basis. With an impressive average annual return of 21.27%, this ETF has garnered attention from both seasoned investors and newcomers...
Continue Reading
Bluestone Resources Secures Final Court Approval for Acquisition Bluestone Resources Inc. (the "Company" or "Bluestone") proudly announces that it has received a final order from the Supreme Court allowing the much-anticipated acquisition by Aura Minerals Inc. The arrangement showcases a significant shift in the direction of the Company, promising exciting developments...
Continue Reading